MailStore V12: A New Level of Security and Simplified Archiving of Cloud Services
MailStore Software GmbH, a leading German specialist for email archiving solutions, is releasing Version 12 of its software today. Users of MailStore Server and the MailStore Service Provider Edition (SPE) benefit from increased security through easier handling and, thanks to MailStore Gateway, from a simpler means of archiving journal emails of cloud services such as Microsoft Office 365. With MailStore V12, email management has become even safer and simpler to use.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190410005098/en/
MailStore Gateway is a free add-on program that allows emails from cloud services such as Microsoft Office 365 and Google G Suite, or from other email servers, to be archived. https://download.mailstore.com/marketing/en/mediakit.zip (Photo: Business Wire)
“Our customers rely on their archived emails being safe and secure,” says Björn Meyn, Product Manager at MailStore. “So it goes without saying that we want to continually improve the safety aspects of our software and adapt to the increasing demands on email security. It’s also important for us to preserve the ease-of-use and positive user experience that are the hallmarks of our software.”
Automated Support of “Let’s Encrypt” Certificates
One innovation in Version 12 of MailStore Server that is particularly worthy of note is the automated support of digital certificates of the independent certificate authority Let’s Encrypt, which offers digital certificates for Transport Layer Security (TSL) encryption free of charge. With this service, MailStore is providing its customers with a simple means to automatically receive and renew official, trusted certificates so that they can build a safe and secure environment. Where required, MailStore Server can help administrators request and configure Let’s Encrypt certificates immediately during installation. What is more, the software takes care of certificate renewal itself so that MailStore Server always has a valid certificate. Alternatively, administrators can use the Installer to create self-signed certificates or access existing certificates.
Simplified Archiving of Cloud Services with MailStore Gateway
MailStore Gateway for MailStore Server and MailStore SPE is a free add-on program. In addition to SMTP and POP3 proxy functions, it provides a simple email server that allows emails from cloud services such as Microsoft Office 365 and Google G Suite, or from other email servers, to be archived. MailStore Gateway was designed primarily with the following scenarios in mind:
- As a server: in this case, MailStore Gateway functions as the target of a journal or archiving rule for other email servers which can themselves create copies of incoming or outgoing emails
- As a proxy: in this scenario, MailStore Gateway operates as an SMTP and POP3 proxy that makes copies of all mails exchanged between email clients and email servers
Security by Design also applies to MailStore Gateway!
All emails stored in MailStore Gateway’s mailboxes are protected by strong hybrid encryption. In principle MailStore Gateway also prohibits user names or passwords from being transferred via unencrypted connections. For this reason, servers to which connections are established via the proxy function must support implicit (SMTPS, POP3S) or explicit (SMTP+STARTTLS, POP3+STARTTLS) encryption.
MailStore Gateway’s Management Console can be accessed by common browsers such as Microsoft Edge, Microsoft IE 10 (and higher versions), as well as by Google Chrome and Mozilla Firefox.
Other Improvements for More Safety and User Friendliness
- MailStore SPE administrators receive a message if a license fails to update.
- When using the Web Client of MailStore Server and MailStore SPE, the browser’s language setting is detected and automatically used.
- As from Version 12, both MailStore Server and MailStore SPE support Microsoft Windows Server 2019.
MailStore Software GmbH from Viersen near Düsseldorf, Germany, is a subsidiary of the U.S. company Carbonite (NASDAQ: CARB), a leading provider of data protection solutions. MailStore is one of the world’s leading providers of email archiving solutions. Over 60,000 companies, public authorities and educational institutions in more than 100 countries have placed their trust in the products of the German specialist.
Also, with its Service Provider Edition (SPE), MailStore offers a solution that is tailored to the needs of service providers, who are able to provide their customers with email archiving as a managed service.
MailStore’s product portfolio also includes MailStore Home, a solution that enables individual home users to archive their private emails free of charge. MailStore Home is currently used by more than 1,000,000 users worldwide.
|Download this report as a PDF file|
|Images for the release||
Caption: MailStore Gateway is a free add-on program that
allows emails from cloud services such as Microsoft Office 365 and
Google G Suite, or from other email servers, to be archived.
|Information on the product portfolio|
Corporate Communications Manager
Tel.: +49 (0)2162 502-99-11
About Business Wire
(c) 2018 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease19.7.2019 17:59:00 CEST | Press release
Celgene Corporation (NASDAQ:CELG) today announced that the U.S. Food and Drug Administration (FDA) has approved OTEZLA® (apremilast) 30 mg twice daily (BID) for the treatment of adult patients with oral ulcers associated with Behçet’s Disease. OTEZLA, an oral, selective inhibitor of phosphodiesterase 4 (PDE4), is the first and only approved treatment option for oral ulcers associated with Behçet’s Disease, a rare, chronic, multisystem inflammatory disease that is difficult to treat. “Oral ulcers are a recurring and debilitating manifestation that affects nearly everyone living with Behçet’s Disease, and have an important negative impact on the quality of life for these patients,” said Yusuf Yazici, M.D., Clinical Associate Professor, Department of Medicine, New York University Langone Health. “In the clinical trial, OTEZLA demonstrated improvements in measures of oral ulcers at week 12. OTEZLA has the potential to be a needed treatment option for U.S. patients and their physicians, who
Abiraterone Acetate Included in World Health Organisation’s Essential Medicines List for the Treatment of Metastatic Castration-Resistant Prostate Cancer19.7.2019 13:05:00 CEST | Press release
The Janssen Pharmaceutical Companies of Johnson & Johnson is delighted with the recent announcement from the World Health Organisation (WHO) to include abiraterone acetate (ZYTIGA ® ) for the treatment of metastatic castration-resistant prostate cancer (mCRPC), in the updated Essential Medicines List, published on 9th July 2019.1,2 The WHO’s Essential Medicines List is a core guidance document that helps countries prioritise critical health products that are recommended to be widely available and affordable throughout health systems.1 “The inclusion of abiraterone acetate in the WHO Essential Medicines List highlights the critical role that this treatment can play in improving the lives of patients living with mCRPC and their families,” said Dr. Joaquín Casariego, Janssen Therapeutic Area Lead Oncology for Europe, Middle East & Africa, Janssen-Cilag S.A. “I am proud that we are working hard to impact survival and quality of life by developing and providing innovative medicines which ar
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis19.7.2019 12:30:00 CEST | Press release
Gilead Sciences, Inc. (NASDAQ: GILD) announced today that it has licensed three preclinical antiviral programs from Novartis, including investigational agents with the potential to treat human rhinovirus, influenza and herpes viruses. Under the agreement, Gilead will acquire exclusive global rights to develop and commercialize novel small molecules against three undisclosed targets. Novartis will receive an upfront payment and is eligible to receive up to an additional $291 million in potential milestone payments upon achievement of certain development and commercial milestones, as well as royalties on annual net sales. “Today’s announcement builds on Gilead’s heritage in antiviral research and development. We look forward to applying this expertise to advance the development of potential new treatments for viruses with limited therapeutic options,” said John McHutchison AO, MD, Gilead’s Chief Scientific Officer and Head of Research and Development. Gilead’s antiviral portfolio include
Schlumberger Announces Second-Quarter 2019 Results19.7.2019 11:00:00 CEST | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the second quarter of 2019. (Stated in millions, except per share amounts) Three Months Ended Change Jun. 30, 2019 Mar. 31, 2019 Jun. 30, 2018 Sequential Year-on-year Revenue $8,269 $7,879 $8,303 5% 0% Pretax segment operating income $968 $908 $1,094 7% -12% Pretax segment operating margin 11.7% 11.5% 13.2% 17 bps -148 bps Net income - GAAP basis $492 $421 $430 17% 14% Net income, excluding charges & credits* $492 $421 $594 17% -17% Diluted EPS - GAAP basis $0.35 $0.30 $0.31 17% 13% Diluted EPS, excluding charges & credits* $0.35 $0.30 $0.43 17% -19% North America revenue $2,801 $2,738 $3,139 2% -11% International revenue $5,463 $5,037 $5,065 8% 8% North America revenue, excluding Cameron $2,243 $2,178 $2,546 3% -12% International revenue, excluding Cameron $4,761 $4,469 $4,387 7% 9% *These are non-GAAP financial measures. See section titled "Charges & Credits" for details. Schlumberger Chairman and CEO Paal Kibsgaard commente
Schlumberger Appoints Olivier Le Peuch as CEO19.7.2019 10:46:00 CEST | Press release
Schlumberger Limited (NYSE: SLB) announced today that its Board of Directors has appointed Olivier Le Peuch as its Chief Executive Officer and member of the Schlumberger Board, effective August 1, 2019. Mr. Le Peuch succeeds Paal Kibsgaard, who will retire as Chief Executive Officer effective that same date. Also effective August 1, Mr. Kibsgaard will step down as Chairman of the Board and retire as a member of the Board of Directors. Mr. Kibsgaard will retire after more than 22 years of service to the Company, including eight years as CEO and four years as Chairman. Effective the same date, Mark G. Papa, a current non-independent director, will become non-executive Chairman of the Board. Peter Currie will continue to serve as the Board’s Lead Independent Director. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190719005161/en/ Olivier Le Peuch is appointed Chief Executive Officer and a member of the Schlumberger Board, effe
Fluke Corporation Acquires Industrial Reliability Leader PRÜFTECHNIK19.7.2019 10:00:00 CEST | Press release
Fluke Corp., the global leader in test and measurement instruments, has acquired Ismaning, Germany-based PRÜFTECHNIK, a market leader in precision laser shaft alignment, condition monitoring, and non-destructive testing. “Fluke’s acquisition of PRÜFTECHNIK reflects the growing importance our customers place on reliability systems to keep their equipment in optimum operating condition,” said Marc Tremblay, president of Fluke Corporation. “This business will help us usher in the next generation of solutions for our industrial customers.” Fluke Corporation For information on Fluke tools and applications, or to find the location of your nearest distributor, contact Fluke Corporation, P.O. Box 9090, Everett, WA USA 98206, call (800) 44-FLUKE (800-443-5853), fax (425) 446-5116, e-mail email@example.com or visit the Fluke Web site at http://www.fluke.com. About Fluke Founded in 1948, Fluke Corporation is the world leader in compact, professional electronic test tools and software for measu